Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Plasma S100β is a predictor for pathology and cognitive decline in Alzheimer's disease 2025-01-09
  2. Homocysteine - A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia 2022-12-09
  3. CSF biomarkers and plasma p-tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial design 2022-02-28

Studies

5 studies carry this tag.

Date range

2004 to 2025

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • Experimental gerontology 1
  • Fluids and barriers of the CNS 1
  • Molecular psychiatry 1
  • PloS one 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Plasma S100β is a predictor for pathology and cognitive decline in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Fluids and barriers of the CNS 2025-01-09 Biomarkers

    The goal of this study was to assess markers for barrier dysfunction in postmortem tissue samples from research participants who were either cognitively normal individuals (CNI) or diagnosed with AD at the time of autopsy and determine to what extent these markers are associated with AD neuropathologic changes (ADNC) and cognitive impairment.

  2. Homocysteine - A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Experimental gerontology 2022-12-09 Biomarkers

    The results of this study suggest that homocysteine levels are independently associated with impaired cognitive function and increased five-year mortality.

  3. CSF biomarkers and plasma p-tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial design

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2022-02-28 Biomarkers

    Clinical trials testing tau-targeting therapies may benefit from using fluid biomarkers to recruit individuals at risk of tau aggregation.

  4. Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. PloS one 2011-07-21 Tau biomarkers

    Prediction of conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD) is of major interest in AD research.

  5. Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Molecular psychiatry 2004-07-01 Tau biomarkers

    Subjects with mild cognitive impairment (MCI) are at a high risk of developing clinical Alzheimer's disease (AD).

All topic tags with their study counts